Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 4 | 2025 | 630 | 0.870 |
Why?
|
| Neoplastic Stem Cells | 3 | 2025 | 399 | 0.430 |
Why?
|
| Oxidative Stress | 7 | 2014 | 1317 | 0.410 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2025 | 55 | 0.390 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2023 | 406 | 0.330 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 97 | 0.310 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 106 | 0.300 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 363 | 0.280 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 365 | 0.280 |
Why?
|
| Aryldialkylphosphatase | 6 | 2014 | 18 | 0.260 |
Why?
|
| Hematopoiesis | 2 | 2022 | 192 | 0.210 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2023 | 16 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 1 | 2025 | 411 | 0.190 |
Why?
|
| RNA Splicing Factors | 1 | 2022 | 53 | 0.190 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2021 | 25 | 0.180 |
Why?
|
| Lipids | 4 | 2012 | 672 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 422 | 0.150 |
Why?
|
| Antioxidants | 2 | 2014 | 584 | 0.150 |
Why?
|
| Atherosclerosis | 2 | 2012 | 415 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1991 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 243 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2025 | 1719 | 0.130 |
Why?
|
| Serbia | 2 | 2011 | 7 | 0.110 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 120 | 0.090 |
Why?
|
| Reference Values | 2 | 2011 | 816 | 0.090 |
Why?
|
| Volleyball | 1 | 2011 | 10 | 0.090 |
Why?
|
| Physical Education and Training | 1 | 2011 | 76 | 0.090 |
Why?
|
| Malnutrition | 1 | 2012 | 83 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2025 | 5079 | 0.080 |
Why?
|
| Smoking | 2 | 2014 | 1627 | 0.080 |
Why?
|
| Weight Gain | 1 | 2012 | 519 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 168 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 77 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 622 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 2008 | 116 | 0.070 |
Why?
|
| Humans | 14 | 2025 | 137585 | 0.070 |
Why?
|
| Pregnancy | 3 | 2014 | 6763 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 570 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 617 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2008 | 385 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3412 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 139 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 872 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 3284 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 698 | 0.050 |
Why?
|
| Inflammation | 2 | 2012 | 2837 | 0.040 |
Why?
|
| Malondialdehyde | 2 | 2012 | 29 | 0.040 |
Why?
|
| Spindle Apparatus | 1 | 2021 | 102 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 316 | 0.040 |
Why?
|
| Adult | 6 | 2014 | 37929 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2012 | 3556 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2012 | 1024 | 0.040 |
Why?
|
| Linear Models | 2 | 2012 | 849 | 0.040 |
Why?
|
| Proteins | 1 | 2025 | 1009 | 0.040 |
Why?
|
| Renal Dialysis | 2 | 2012 | 435 | 0.040 |
Why?
|
| Dietary Supplements | 2 | 2014 | 561 | 0.040 |
Why?
|
| Female | 8 | 2014 | 73304 | 0.040 |
Why?
|
| Phenotype | 3 | 2011 | 3196 | 0.030 |
Why?
|
| Proteomics | 1 | 2022 | 1111 | 0.030 |
Why?
|
| Mice | 2 | 2025 | 17787 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2014 | 30 | 0.030 |
Why?
|
| Middle Aged | 3 | 2012 | 33479 | 0.030 |
Why?
|
| Advanced Oxidation Protein Products | 1 | 2012 | 1 | 0.030 |
Why?
|
| Vitamins | 1 | 2014 | 185 | 0.020 |
Why?
|
| Apoptosis | 1 | 2021 | 2553 | 0.020 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2012 | 90 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2475 | 0.020 |
Why?
|
| Male | 4 | 2012 | 67762 | 0.020 |
Why?
|
| Young Adult | 3 | 2012 | 13209 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 410 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 530 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2011 | 3457 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2012 | 346 | 0.020 |
Why?
|
| Animals | 2 | 2025 | 36940 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2012 | 176 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 524 | 0.020 |
Why?
|
| Athletic Performance | 1 | 2011 | 79 | 0.020 |
Why?
|
| Biomarkers | 2 | 2011 | 4149 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 889 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1316 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 275 | 0.020 |
Why?
|
| Paraoxon | 1 | 2008 | 2 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 910 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 1060 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 314 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2008 | 78 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1509 | 0.020 |
Why?
|
| Athletes | 1 | 2011 | 423 | 0.020 |
Why?
|
| Particle Size | 1 | 2008 | 394 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 708 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 2844 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 2389 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 2074 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2011 | 2186 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 6828 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 7604 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 2111 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 10388 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 21513 | 0.010 |
Why?
|
| Child | 1 | 2012 | 21935 | 0.010 |
Why?
|